Aberrant methylation of MUC1 and MUC4 promoters are potential prognostic biomarkers for pancreatic ductal adenocarcinomas (Q39544250)

From Wikidata
Jump to navigation Jump to search
scientific article published on 8 June 2016
edit
Language Label Description Also known as
English
Aberrant methylation of MUC1 and MUC4 promoters are potential prognostic biomarkers for pancreatic ductal adenocarcinomas
scientific article published on 8 June 2016

    Statements

    Aberrant methylation of MUC1 and MUC4 promoters are potential prognostic biomarkers for pancreatic ductal adenocarcinomas (English)
    Seiya Yokoyama
    Michiyo Higashi
    Sho Kitamoto
    Monika Oeldorf
    Uwe Knippschild
    Marko Kornmann
    Kosei Maemura
    Hiroshi Kurahara
    Tomofumi Hamada
    Ikumi Kitazono
    Takashi Tasaki
    Tsubasa Hiraki
    Kazuhito Hatanaka
    Yuko Mataki
    Hiroki Taguchi
    Shinichi Hashimoto
    Surinder K Batra
    Akihide Tanimoto
    Suguru Yonezawa
    42553-42565

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit